Propelling: Taking the Future of Construction to the Skies

 

Drones are creating new workflows, processes and applications in construction design, surveying and mapping, and many see them as the future of the construction industry.

Rick Rayhel, Microdrones‘ Sales Manager for United States’ Western Region, is one of those people; he’s seen first hand how drones can enhance the construction business.

In the U.S., drones have only been used to aid construction in the last couple of years. On the precipice of drone potential, Rayhel said, “There’s never a lack of ideas or interest on what can be done with drones.”

Today, drones are used for volume metrics, aerial photos, mapping, and 3D sketching to name a few applications. Drones assist in the many stages of a construction job, including monitoring safety and progress.

Perhaps the biggest advantage of drones in construction, though, is their cost-effectiveness. On this episode of Propelling,Rayhel emphasizes that UAVs can save a company thousands of dollars in manpower. Instead of filing costly insurance claims after a safety incident, these vulnerabilities can be found before they lead to damage. Instead of laborious and often treacherous ground scanning done by humans, a UAV can collect data quickly and efficiently.

Rayhel dives into detail about what to look for in a drone for construction work, and he divulges what crucial questions to ask before bringing UAVs into a business model.

For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @AECMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More